[Natraemia, natriuresis, inhibitors of sodium transport and high blood pressure].
Hugh
H
de Wardener
D000818:Animals; D001685:Biological Factors / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology; D001693:Biological Transport, Active / Q000187:drug effects; D004285:Dogs; D004730:Endothelium, Vascular / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000209:etiology / Q000503:physiopathology*; D007031:Hypothalamus / Q000378:metabolism; D008954:Models, Biological; D009318:Natriuresis / Q000502:physiology*; D045265:Natriuretic Peptides / Q000502:physiology; D051381:Rats; D012964:Sodium / Q000097:blood / Q000378:metabolism*; D012982:Sodium, Dietary / Q000009:adverse effects; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors* / Q000502:physiology; D014882:Water-Electrolyte Balance / Q000502:physiology
D001685:Biological Factors; D045265:Natriuretic Peptides; D012982:Sodium, Dietary; D012964:Sodium; D000254:Sodium-Potassium-Exchanging ATPase